TACT Act of 2023 Timely Access to Clinical Treatment Act of 2023
Impact
If enacted, the TACT Act would significantly alter healthcare delivery systems related to oral medications by removing barriers for patients regarding prescription fulfillment. It specifically addresses delays typically caused by prior authorization processes and stipulates that health plans must cover prescriptions even from alternate providers if a pharmacy is unable to deliver on time. The bill aims to improve overall health outcomes by ensuring that patients have timely access to necessary medications, thereby reducing the period of uncertainty and potential health risks associated with delayed treatments.
Summary
House Bill 4011, also known as the Timely Access to Clinical Treatment Act of 2023 (TACT Act), proposes amendments to Title XXVII of the Public Health Service Act aimed at enhancing patient access to oral medications. The bill introduces requirements for health plans and insurance issuers concerning their contracts with pharmacies, stipulating that they must ensure timely dispensing of prescriptions for oral medications. Specifically, the bill mandates that pharmacies confirm their capability to fill a prescription within 24 hours and dispense the medication within a further defined timeframe, which enhances operational efficiencies in providing medication to patients.
Contention
Despite its goals, the implementation of HB4011 has sparked discussions around the feasibility of enforcing these regulations among various healthcare stakeholders. Critics argue that the stringent timelines may be unrealistic for pharmacies, especially smaller, independent ones that might lack the necessary resources to comply effectively. Furthermore, there are concerns about how these changes might impact cost-sharing calculations between pharmacies and health plans, as well as the potential for increased healthcare costs if not managed appropriately. Stakeholders are particularly interested in how the amendments will affect long-term patient care and medication adherence.